SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-219091
Filing Date
2023-08-23
Accepted
2023-08-23 16:02:04
Documents
14
Period of Report
2023-08-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d506467d8k.htm   iXBRL 8-K 26381
2 EX-99.1 d506467dex991.htm EX-99.1 122419
  Complete submission text file 0001193125-23-219091.txt   321441

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dna-20230823.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20230823_def.xml EX-101.DEF 13637
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20230823_lab.xml EX-101.LAB 22561
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20230823_pre.xml EX-101.PRE 14604
8 EXTRACTED XBRL INSTANCE DOCUMENT d506467d8k_htm.xml XML 5303
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 231197574
SIC: 2836 Biological Products, (No Diagnostic Substances)